Serum Levels of Three Angiogenic Factors in Systemic Lupus Erythematosus and Their Clinical Significance

Table 1

Clinical data among groups (mean ± standard deviation).

	Control group	All SLE group	Active SLE group	Inactive SLE group
Number of cases	28	54	36	18
Age	37.82±12.86	36.81±12.52	34.50±11.84	41.44±12.91
Gender (F/M)	22/6	50/4	34/2	16/2
SBP (mmHg)	120.11±14.27	126.39±27.28	130.28±28.79	118.61±22.81
DBP (mmHg)	72.54±8.39	80.69 ± 18.867^a	84.36 ± 19.97^b	73.33 ± 14.25^d
Hb (g/L)	145.89±13.192	113.96 ± 20.84^a	108.22 ± 21.71^b	125.44 ± 13.19^cd
Plt (109/L)	196.29±39.93	167.31 ± 83.35^a	165.36 ± 95.04	171.22 ± 55.11
TC (mmol/L)	4.89±1.19	5.56 ± 2.41	5.78 ± 2.58	5.12 ± 12.03
TG (mmol/L)	1.63±1.00	2.20 ± 1.43	2.42 ± 1.62^b	1.74 ± 0.79^d
Alb (g/L)	45.20±2.42	33.42 ± 8.18^a	31.80 ± 7.88^b	36.68 ± 8.00^cd
Cr-s (µmol/L)	60.25±13.36	86.66 ± 68.23	97.03 ± 81.57^b	65.92 ± 11.50^d
UA (mmol/L)	339.29±91.91	314.24 ± 134.31	330.93 ± 155.32	280.85 ± 69.29^c
FBG (mmol/L)	5.84±0.97	5.10 ± 0.89^a	5.17 ± 0.09^b	4.95 ± 0.91^c

Note: When compared with the control group, ^a𝑃<0.05, ^b𝑃<0.05, and ^c𝑃<0.05; When compared with the active SLE group, ^d𝑃<0.05.